Factors of hand-foot skin reacion associated with multi kinase inhibitor for hepatocellular carcinoma

Factors of hand-foot skin reacion associated with multi kinase inhibitor for hepatocellular carcinoma - Factors of hand-foot skin reacion associated with multi kinase inhibitor for hepatocellular carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039509

Enrollment

Registered

2020-02-18

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who treated by lenvatinib, sorafenib and regorafenib for unresectable hepatocellular carcinoma

Exclusion criteria

Exclusion criteria: 1. Under 20 years old 2. Not have the ability to walk by themselves 3. Who could not obtain the concent to participate in this study within one week after starting treatment 4. Have severe mental disorders (such as severe depression) 5. Not have the ability of informed concent 6. Be decided to unsuitable for the study by his/her doctor

Design outcomes

Primary

Measure	Time frame
Factors of hand-foot skin reaction in the sole of the foot for two months after starting treatment	—

Secondary

Measure	Time frame
clinical data, number of steps, foot deformities, shoe shape, external force applied to foot, self-care implementation	—

Countries

Japan

Contacts

Public ContactYukie Tahara

Graduate School of Nursing, Chiba University Department of Nursing Physiology

taharay@chiba-u.jp043-222-7171(ext.5711)

Outcome results